Treatment Patterns Among Adults with Primary Immune Thrombocytopenia Diagnosed in Hematology Clinics in the United States

References

• Terrell DR, Beebe LA, Vesely SK, Neas BR, Segal JB, George JN. The incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reports. Am J Hematol. 2010;85(3):174–180.20131303
   PubMed Web of Science ®Google Scholar
• Cines DB, Bussel JB. How I treat idiopathic thrombocytopenic purpura (ITP). Blood. 2005;106(7):2244–2251. doi:10.1182/blood-2004-12-459815941913
   PubMed Web of Science ®Google Scholar
• Cooper N. Intravenous immunoglobulin and anti-RhD therapy in the management of immune thrombocytopenia. Hematol Oncol Clin North Am. 2009;23(6):1317–1327. doi:10.1016/j.hoc.2009.09.00219932436
   PubMed Web of Science ®Google Scholar
• Kitchens CS, Pendergast JF. Human thrombocytopenia is associated with structural abnormalities of the endothelium that are ameliorated by glucocorticosteroid administration. Blood. 1986;67(1):203–206. doi:10.1182/blood.V67.1.203.2033940548
   PubMed Web of Science ®Google Scholar
• Newland AC, Treleaven JG, Minchinton RM, Waters AH. High-dose intravenous IgG in adults with autoimmune thrombocytopenia. Lancet. 1983;1(8316):84–87. doi:10.1016/S0140-6736(83)91738-56129456
   PubMed Web of Science ®Google Scholar
• Cetin K, Wetten S, Christiansen C, Norgaard M, Heide-Jorgensen U. Recent time trends in the uptake of splenectomy in adults diagnosed with chronic immune thrombocytopenia: a nationwide historical cohort study in Denmark, 1996–2012. Haematologica. 2015;100(Suppl 1):566.
   Google Scholar
• Palandri F, Polverelli N, Sollazzo D, et al. Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years. Am J Hematol. 2016;91(4):E267–E272. doi:10.1002/ajh.2431026799593
   PubMed Web of Science ®Google Scholar
• Lambert MP, Gernsheimer TB. Clinical updates in adult immune thrombocytopenia. Blood. 2017;129(21):2829–2835. doi:10.1182/blood-2017-03-75411928416506
   PubMed Web of Science ®Google Scholar
• PROMACTA Prescribing Information. 2018; Available from: https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/promacta.pdf. Accessed 821, 2019.
   Google Scholar
• Nplate Prescribing Information. 2018; Available from: https://www.pi.amgen.com/~/media/amgen/repositorysites/pi-amgen-com/nplate/nplate_pi_hcp_english.pdf. Accessed 821, 2019.
   Google Scholar
• Bussel JB, Provan D, Shamsi T, et al. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial. Lancet. 2009;373(9664):641–648. doi:10.1016/S0140-6736(09)60402-519231632
   PubMed Web of Science ®Google Scholar
• Kuter DJ, Bussel JB, Lyons RM, et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet. 2008;371(9610):395–403. doi:10.1016/S0140-6736(08)60203-218242413
   PubMed Web of Science ®Google Scholar
• Bussel JB, Kuter DJ, Pullarkat V, Lyons RM, Guo M, Nichol JL. Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP. Blood. 2009;113(10):2161–2171. doi:10.1182/blood-2008-04-15007818981291
   PubMed Web of Science ®Google Scholar
• Bussel J, Arnold DM, Grossbard E, et al. Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: results of two Phase 3, randomized, placebo-controlled trials. Am J Hematol. 2018;93(7):921–930. doi:10.1002/ajh.2512529696684
   PubMed Web of Science ®Google Scholar
• Provan D, Newland AC. Current management of primary immune thrombocytopenia. Adv Ther. 2015;32(10):875–887. doi:10.1007/s12325-015-0251-z26499177
   PubMed Web of Science ®Google Scholar
• Neunert C, Lim W, Crowther M, et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117(16):4190–4207. doi:10.1182/blood-2010-08-30298421325604
   PubMed Web of Science ®Google Scholar
• Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115(2):168–186. doi:10.1182/blood-2009-06-22556519846889
   PubMed Web of Science ®Google Scholar
• Neunert CE, Cooper N. Evidence-based management of immune thrombocytopenia: ASH guideline update. Hematol Am Soc Hematol Educ Program. 2018;2018(1):568–575. doi:10.1182/asheducation-2018.1.568
   PubMed Web of Science ®Google Scholar
• Lakshmanan S, Cuker A. Contemporary management of primary immune thrombocytopenia in adults. J Thromb Haemost. 2012;10(10):1988–1998. doi:10.1111/j.1538-7836.2012.04876.x22863415
   PubMed Web of Science ®Google Scholar
• Cuker A, Cines DB, Neunert CE. Controversies in the treatment of immune thrombocytopenia. Curr Opin Hematol. 2016;23(5):479–485. doi:10.1097/MOH.000000000000027027380558
   PubMed Web of Science ®Google Scholar
• Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113(11):2386–2393. doi:10.1182/blood-2008-07-16250319005182
   PubMed Web of Science ®Google Scholar
• Aalen O. Nonparametric estimation of partial transition probabilities in multiple decrement models. Ann Stat. 1978;6(3):534–545. doi:10.1214/aos/1176344198
   Web of Science ®Google Scholar
• R: a language and environment for statistical computing computer program. Vienna, Austria: R Foundation for Statistical Computing; 2017.
   Google Scholar
• Cmprsk: subdistribution analysis of competing risks. R package version 2.2-7. computer program; 2014.
   Google Scholar
• McGrath L, Cetin K, Overman R, et al. Real-world patterns of romiplostim treatment in adults with primary immune thrombocytopenia in the United States. Am J Hematol. 2018;93(9):E45–E46. doi:10.1002/ajh.2496529127684
   PubMed Web of Science ®Google Scholar
• Chugh S, Darvish-Kazem S, Lim W, et al. Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis. Lancet Haematol. 2015;2(2):e75–e81. doi:10.1016/S2352-3026(15)00003-426687612
   PubMed Web of Science ®Google Scholar
• Gudbrandsdottir S, Birgens HS, Frederiksen H, et al. Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia. Blood. 2013;121(11):1976–1981. doi:10.1182/blood-2012-09-45569123293082
   PubMed Web of Science ®Google Scholar
• Zaja F, Baccarani M, Mazza P, et al. Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia. Blood. 2010;115(14):2755–2762. doi:10.1182/blood-2009-07-22981520130241
   PubMed Web of Science ®Google Scholar
• Chaturvedi S, Arnold DM, McCrae KR. Splenectomy for immune thrombocytopenia: down but not out. Blood. 2018;131(11):1172–1182. doi:10.1182/blood-2017-09-74235329295846
   PubMed Web of Science ®Google Scholar
• Navez J, Hubert C, Gigot JF, et al. Does the site of platelet sequestration predict the response to splenectomy in adult patients with immune thrombocytopenic purpura? Platelets. 2015;26(6):573–576. doi:10.3109/09537104.2014.95991525275667
   PubMed Web of Science ®Google Scholar
• Ghanima W, Godeau B, Cines DB, Bussel JB. How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment. Blood. 2012;120(5):960–969. doi:10.1182/blood-2011-12-30915322740443
   PubMed Web of Science ®Google Scholar
• Weide R, Feiten S, Friesenhahn V, et al. Outpatient management of patients with immune thrombocytopenia (ITP) by hematologists 1995–2014. Oncol Res Treat. 2016;39(1–2):41–44. doi:10.1159/00044276926891217
   PubMed Web of Science ®Google Scholar
• Lozano ML, Revilla N, Gonzalez-Lopez TJ, et al. Real-life management of primary immune thrombocytopenia (ITP) in adult patients and adherence to practice guidelines. Ann Hematol. 2016;95(7):1089–1098. doi:10.1007/s00277-016-2665-327098812
   PubMed Web of Science ®Google Scholar
• Rodeghiero F, Besalduch J, Michel M, Provan D, Grotzinger K, Thompson G. Treatment practices in adults with chronic immune thrombocytopenia - a European perspective. Eur J Haematol. 2010;84(2):160–168. doi:10.1111/j.1600-0609.2009.01361.x19845743
   PubMed Web of Science ®Google Scholar
• Lu KH, George JN, Vesely SK, Terrell DR. Management of primary immune thrombocytopenia, 2012: a survey of oklahoma hematologists-oncologists. Am J Med Sci. 2014;347(3):190–194. doi:10.1097/MAJ.0b013e31827f4dd123462246
   PubMed Web of Science ®Google Scholar
• Altomare I, Cetin K, Wetten S, Wasser JS. Rate of bleeding-related episodes in adult patients with primary immune thrombocytopenia: a retrospective cohort study using a large administrative medical claims database in the US. Clin Epidemiol. 2016;8:231–239. doi:10.2147/CLEP.S10588827382333
   PubMed Web of Science ®Google Scholar
• Li S, Molony JT, Cetin K, Wasser JS, Altomare I. Rate of bleeding-related episodes in elderly patients with primary immune thrombocytopenia: a retrospective cohort study. Curr Med Res Opin. 2017;1–8.
   Web of Science ®Google Scholar
• Bylsma LC, Fryzek JP, Cetin K, et al. Systematic literature review of treatments used for adult immune thrombocytopenia in the second-line setting. Am J Hematol. 2019;94(1):118–132. doi:10.1002/ajh.2530130264861
   PubMed Web of Science ®Google Scholar
• Kojouri K, Vesely SK, Terrell DR, George JN. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood. 2004;104(9):2623–2634. doi:10.1182/blood-2004-03-116815217831
   PubMed Web of Science ®Google Scholar
• Kumar S, Diehn FE, Gertz MA, Tefferi A. Splenectomy for immune thrombocytopenic purpura: long-term results and treatment of postsplenectomy relapses. Ann Hematol. 2002;81(6):312–319. doi:10.1007/s00277-002-0461-812107560
   PubMed Web of Science ®Google Scholar